Direct Interrogation of DNA Content Distribution in Nanoparticles by a Novel Microfluidics-Based Single-Particle Analysis
Source abstract
Abstract
Nonviral gene delivery holds great promise not just as a safer alternative to viral vectors in traditional gene therapy applications, but also for regenerative medicine, induction of pluripotency in somatic cells, and RNA interference for gene silencing. Although it continues to be an active area of research, there remain many challenges to the rational design of vectors. Among these, the inability to characterize the composition of nanoparticles and its distribution has made it difficult to probe the mechanism of gene transfection process, since differences in the nanoparticle-mediated transfection exist even when the same vector is used. There is a lack of sensitive methods that allow for full characterization of DNA content in single nanoparticles and its distribution among particles in the same preparation. Here we report a novel spectroscopic approach that is capable of interrogating nanoparticles on a particle-by-particle basis. Using PEI/DNA and PEI-g-PEG/DNA nanoparticles as examples, we have shown that the distribution of DNA content among these nanoparticles was relatively narrow, with the average numbers of DNA of 4.8 and 6.7 per particle, respectively, in PEI/DNA and PEI-g-PEG/DNA nanoparticles. This analysis enables a more accurate description of DNA content in polycation/DNA nanoparticles. It paves the way toward comparative assessments of various types of gene carriers and provides insights into bridging the efficiency gap between viral and nonviral vehicles.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Virus-based gene therapy research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biomedical Engineering, Johns Hopkins School of Medicine, 720 Rutland Avenue, Baltimore, Maryland 21205, United States
Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland 21212, United States
Translational Tissue Engineering Center, Johns Hopkins School of Medicine, 400 North Broadway, Baltimore, Maryland 21287, United States
Funding
Agency for Science, Technology and Research · National Institutes of Health
References (40)
Show source-provided references
1. Sheyn D. · Adv. Drug Delivery Rev. · 2010 · 62 · 68310.1016/j.addr.2010.01.002 ↗
2. Beh C. W. · Biomacromolecules · 2008 · 10 · 4110.1021/bm801109g ↗
3. Whitehead K. A. · Nat. Rev. Drug Discovery · 2009 · 8 · 12910.1038/nrd2742 ↗
4. Yusa K. · Nat. Methods · 2009 · 6 · 36310.1038/nmeth.1323 ↗
5. Varga C. M. · Gene Ther. · 2005 · 12 · 102310.1038/sj.gt.3302495 ↗
6. van Gaal E. V. B. · Int. J. Pharm. · 2010 · 390 · 7610.1016/j.ijpharm.2009.08.032 ↗
7. Hama S. · Mol. Ther. · 2006 · 13 · 78610.1016/j.ymthe.2005.10.007 ↗
8. Putnam D. · Nat. Mater. · 2006 · 5 · 43910.1038/nmat1645 ↗
9. Symens N. · Mol. Pharmacol. · 2013 · 10 · 107010.1021/mp300569j ↗
10. Rajendra Y. · Biotechnol. Bioeng. · 2012 · 109 · 227110.1002/bit.24494 ↗
11. Adler A. F. · Nano Today · 2010 · 5 · 55310.1016/j.nantod.2010.10.007 ↗
12. Majewski A. P. · Biomacromolecules · 2013 · 14 · 308110.1021/bm400703d ↗
13. Miyata K. · Chem. Soc. Rev. · 2012 · 41 · 256210.1039/C1CS15258K ↗
14. De Smedt S. C. · Pharm. Res. · 2000 · 17 · 11310.1023/A:1007548826495 ↗
15. Gillard M. · Polym. Chem. · 2014 · 5 · 337210.1039/C4PY00176A ↗
16. Pitard B. · Proc. Natl. Acad. Sci. U.S.A. · 1997 · 94 · 1441210.1073/pnas.94.26.14412 ↗
17. Kreiss P. · Nucleic Acids Res. · 1999 · 27 · 379210.1093/nar/27.19.3792 ↗
18. Bhise N. S. · Small · 2012 · 8 · 36710.1002/smll.201101718 ↗
19. Collins L. · Biochim. Biophys. Acta, Gen. Subj. · 2004 · 1672 · 1210.1016/j.bbagen.2004.02.004 ↗
20. Ho Y.-P. · J. Controlled Release · 2006 · 116 · 8310.1016/j.jconrel.2006.09.005 ↗
21. Liu K. J. · Biophys. J. · 2008 · 95 · 296410.1529/biophysj.108.132472 ↗
22. Liu K. J. · J. Am. Chem. Soc. · 2010 · 132 · 579310.1021/ja100342q ↗
23. Mutch S. A. · Biophys. J. · 2007 · 92 · 292610.1529/biophysj.106.101428 ↗
24. Mutch S. A. · Nat. Protocols · 2011 · 6 · 195310.1038/nprot.2011.414 ↗
25. Limpert E. · Bioscience · 2001 · 51 · 34110.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2 ↗
26. Zhang Y. · ACS Nano · 2011 · 6 · 85810.1021/nn204377k ↗
27. Neish C. S. · Br. J. Pharmacol. · 2002 · 135 · 194310.1038/sj.bjp.0704660 ↗
28. Fortune J. A. · J. Drug Delivery · 2011 · 2011
29. Gruber H. J. · Bioconjugate Chem. · 2000 · 11 · 69610.1021/bc000015m ↗
30. Berlier J. E. · J. Histochem. Cytochem. · 2003 · 51 · 169910.1177/002215540305101214 ↗
31. Kang J. · Int. J. Polym. Sci. · 2010 · 2010 · 110.1155/2010/264781 ↗
32. Kuznetsova S. · Anal. Biochem. · 2006 · 350 · 5210.1016/j.ab.2005.11.036 ↗
33. Schobel U. · J. Fluoresc. · 2000 · 10 · 14710.1023/A:1009443125878 ↗
34. Mao S. · Bioconjugate Chem. · 2006 · 17 · 120910.1021/bc060129j ↗
35. Albuzat T. · J. Mater. Chem. · 2012 · 22 · 855810.1039/c2jm16425f ↗
36. Grigsby C. L. · Sci. Rep. · 2013 · 3 · 110.1038/srep03155 ↗
37. Chu D. S. H. · Acc. Chem. Res. · 2012 · 45 · 108910.1021/ar200242z ↗
38. Yu J. · Science · 2007 · 318 · 191710.1126/science.1151526 ↗
39. Wang H. · Gene Ther. · 2013 · 20 · 12810.1038/gt.2012.1 ↗
40. Greber D. · Biotechnol. Bioeng. · 2007 · 96 · 82110.1002/bit.21303 ↗